Franklin, Tennessee-based DiaTech, which helps oncologists determine cancer treatments for patients, has secured $75 million in financing. The backer is Keyholder Investments. Also, DiaTech has named Dr. Ronald Krall, Daniel Tasse, and Dr. Lawrence Van Horn to its board.